Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma

Fig. 3

Mix + GalCer treatment induces an increment of iNKT and NK cells. a Percentage of iNKT cells in spleen 3 days after injection of Mix, α-GalCer or Mix + GalCer treatment (n = 4 per group). iNKT cells were analyzed by flow cytometry and gated as TCRβ+ and Tet-PBS57+ cells. b Percentage of NK cells in spleen 3 days after Mix, α-GalCer or Mix + GalCer treatment (n = 2 per group), analyzed by flow cytometry as CD3− NKp46+ cells. **p < 0.005; ***p < 0.0005

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us